Author

Ana Domostegui

Institute for Research in BiomedicineORCID 0000-0002-7642-9757Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Cristina Mayor‐RuiziD· 1 shared Gonzalo AizpuruaiD· 1 shared Inés María García-PéreziD· 1 shared Laura de la Puente OvejeroiD· 1 shared Lucia Lomba-RiegoiD· 1 shared Mariano BarbacidiD· 1 shared Pilar Ximénez‐EmbúniD· 1 shared Sara García‐AlonsoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cristina Mayor‐RuizORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer

Laura de la Puente Ovejero, Ana Domostegui, Inés María García-Pérez, Gonzalo Aizpurua, Lucia Lomba-Riego, Pilar Ximénez‐Embún, Cristina Mayor‐Ruiz, Mariano Barbacid, Sara García‐Alonso

This study shows that chemogenetic degradation of RAF1 in KRAS-driven lung cancer does not replicate genetic ablation outcomes due to scaffold disruption.

bioRxiv · Jul 6, 2026 · PreprintCancer Biology